Development of this evidence summary
This evidence summary was developed for NICE by Bazian Ltd. The interim process statement sets out the process NICE uses to select topics for the evidence summaries for unlicensed/off-label medicines and how the summaries are developed, quality assured and approved for publication.
Project team
Bazian Ltd
Louisa Crossley, Medicines and Prescribing Centre, NICE
Peer reviewers and contributors
Teresina Pinnington, ARJUN Products Ltd
Victoria Thomas, Patient and Public Involvement Programme, NICE
Expert advisers
Dr John Ayuk, Department of Endocrinology, Queen Elizabeth Hospital, Birmingham
Declarations of interest
No relevant interests declared.